We welcome Karla Childers to AI Uncovered. Karla is a long-standing leader in bioethics and data transparency in the pharmaceutical industry. As part of the Office of the Chief Medical Officer at Johnson & Johnson, she brings deep expertise in navigating the ethical implications of emerging technologies, especially artificial intelligence, in medicine and drug development. In this episode, Tim and Karla explore the intersection of AI, bioethics and patient-centered development. They discu...
All content for AI Uncovered is the property of Timothy Martin, Executive VP of Product at Yseop and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
We welcome Karla Childers to AI Uncovered. Karla is a long-standing leader in bioethics and data transparency in the pharmaceutical industry. As part of the Office of the Chief Medical Officer at Johnson & Johnson, she brings deep expertise in navigating the ethical implications of emerging technologies, especially artificial intelligence, in medicine and drug development. In this episode, Tim and Karla explore the intersection of AI, bioethics and patient-centered development. They discu...
Emmanuel Walckenaer - "In the next five years, 80% of the life sciences industry will be using this type of AI"
AI Uncovered
29 minutes
2 years ago
Emmanuel Walckenaer - "In the next five years, 80% of the life sciences industry will be using this type of AI"
The second episode features a conversation with Emmanuel Walckenaer, CEO of Yseop. Yseop is reimagining the future of scientific writing through generative AI. The company's mission is to get medicine into the hands of those who need it, faster.Tim and Emmanuel shares insights on the state of natural language generation (NLG) today and the roots of the technology. They discuss how generative AI is automating parts of the clinical document landscape and why the tech is helping scientific write...
AI Uncovered
We welcome Karla Childers to AI Uncovered. Karla is a long-standing leader in bioethics and data transparency in the pharmaceutical industry. As part of the Office of the Chief Medical Officer at Johnson & Johnson, she brings deep expertise in navigating the ethical implications of emerging technologies, especially artificial intelligence, in medicine and drug development. In this episode, Tim and Karla explore the intersection of AI, bioethics and patient-centered development. They discu...
